---
title: "4D Molecular Therapeutics CEO David Kirn disposes of 12,415 shares worth $124,987"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294871283.md"
description: "4D Molecular Therapeutics CEO David Kirn sold 12,415 common shares on August 3, 2026, at a weighted average price of $10.05 per share, totaling approximately $124,987. Following this transaction, Kirn retained a holding of 871,737 shares. The disclosure was filed via EDGAR."
datetime: "2026-08-04T20:53:35.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294871283.md)
  - [en](https://longbridge.com/en/news/294871283.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294871283.md)
generator: "portal-rs"
---

# 4D Molecular Therapeutics CEO David Kirn disposes of 12,415 shares worth $124,987

-   4D Molecular Therapeutics President, CEO, director David Kirn sold 12,415 common shares on Aug. 3, 2026. \* Shares sold at a weighted average price of $10.05. \* Kirn held 871,737 shares following the transaction. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 4D Molecular Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-333014), on August 04, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [FDMT.US](https://longbridge.com/en/quote/FDMT.US.md)

## Related News & Research

- [4D Molecular Therapeutics CEO David Kirn disposes of common shares worth $1,068,651.63](https://longbridge.com/en/news/296648682.md)
- [4D Molecular Therapeutics posts corporate presentation highlighting AAV gene therapy pipeline led by 4D-150 for wet AMD, DME](https://longbridge.com/en/news/296635019.md)
- [Agilysys Insiders Sold Shares Worth Over $1.6M](https://longbridge.com/en/news/296401909.md)
- [Mark Brosius Sells 77 Shares of Intuitive Surgical (NASDAQ:ISRG) Stock](https://longbridge.com/en/news/296661262.md)
- [Mercury Systems (NASDAQ:MRCY) EVP Steven Ratner Sells 2,187 Shares](https://longbridge.com/en/news/296653562.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**